Skip to main content

Advertisement

Table 1 Clinical echocardiographic parameters in KD and control

From: Quantitative evaluation of myocardial fibrosis by cardiac integrated backscatter analysis in Kawasaki disease

  KD (acute) KD (subacute) KD (convalescence) Healthy control p
Left Ventricle      
M-mode      
 LV EDD (mm) 33.6 ± 3.4 32.9 ± 3.6 33.3 ± 3.2 32.7 ± 2.5 0.56
 LV ESD (mm) 17.1 ± 1.9 17.6 ± 1.4 16.9 ± 2.0 17.2 ± 1.7 0.32
 IVSd (mm) 4.2 ± 0.5 4.3 ± 0.3 4.1 ± 0.4 4.1 ± 0.3 0.38
 LV PWd (mm) 4.0 ± 0.4 4.1 ± 0.4 4.0 ± 0.5 4.1 ± 0.4 0.62
 LV mass (g) 22.9 ± 0.4 22.3 ± 0.5 22.8 ± 0.5 23.0 ± 0.4 0.33
 LV eject fraction (%) 68.3 ± 4.2 70.2 ± 6.1 69.5 ± 5.7 68.9 ± 5.5 0.14
Mitral inflow velocities      
 E (cm/s) 97.7 ± 10.2 105.4 ± 9.7 93.8 ± 13.5 98.7 ± 12.5 0.49
 A (cm/s) 59.9 ± 12.5 57.5 ± 14.7 61.4 ± 13.2 62.3 ± 11.9 0.78
 E/A ratio 1.6 ± 0.4 1.8 ± 0.4 1.5 ± 0.3 1.6 ± 0.4 0.65
Right ventricle      
Tricuspid inflow velocities      
 E (cm/s) 71.0 ± 12.1 74.3 ± 10.5 69.8 ± 8.4 73.4 ± 15.1 0.84
 A (cm/s) 50.0 ± 6.9 54.9 ± 9.8 53.8 ± 7.3 51.5 ± 5.3 0.33
 E/A ratio 1.4 ± 0.3 1.4 ± 0.2 1.3 ± 0.2 1.4 ± 0.3 0.79
  1. Abbreviations: KD Kawasaki disease, LV left ventricle, EDD end-diastolic dimension, ESD end-systolic dimension, IVSd interventricular septal thickness at diastole, PWd posterior wall thickness at diastole